Publications by authors named "G Kunkel"

Oxidant-free Au(I)/Au(III)-catalyzed cross-coupling has been recently enabled by the use of bidentate ,-ligands. To further develop these ,-ligands, computational studies were performed to understand their effects on the oxidative addition of aryl iodide electrophiles with Au(I). Using this mechanistic understanding, six new electron-rich ,-ligands were synthesized.

View Article and Find Full Text PDF

Objective: Investigate the association between the MUC5B rs35705950 promoter variant and survival in RA-associated interstitial lung disease (RA-ILD).

Methods: We studied participants in the Veteran Affairs Rheumatoid Arthritis (VARA) registry with validated ILD diagnoses. Participants were followed until death or end of study period.

View Article and Find Full Text PDF
Article Synopsis
  • - Organometallic oxidative addition complexes (OACs) are gaining attention as effective reagents for the selective modification of biomolecules by altering ligand and aryl properties to control reaction kinetics and regioselectivity.
  • - Researchers explored the use of bidentate Au(III) OACs with bulky and electron-deficient aryl substrates to successfully achieve selective -arylation using computational and experimental methods.
  • - The study successfully developed a protein-polymer OAC that performed rapid -arylation with designed ankyrin repeat proteins (DARPins) and various biologically relevant small molecules, paving the way for constructing complex biomolecular conjugates.
View Article and Find Full Text PDF

Introduction: Fluvoxamine is used in children and adolescents ('youths') for treating obsessive compulsive disorder (OCD) but also off-label for depressive and anxiety disorders. This study aimed to investigate the relationship between fluvoxamine dose and serum concentrations, independent correlates of fluvoxamine concentrations, and a preliminary therapeutic reference range (TRR) for youths with OCD and treatment response.

Methods: Multicenter naturalistic data of a therapeutic drug monitoring service, as well as prospective data of the 'TDM Vigil study' (EudraCT 2013-004881-33), were analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • Bioconjugation of polymers to proteins can enhance the stability and effectiveness of biologic systems, but the impact of different polymer structures is not fully understood.
  • This study focuses on the first bioconjugation of a cyclic polymer, specifically poly(ethylene glycol), to a model protein (T4 lysozyme) to explore its unique properties.
  • By comparing the cyclic polymer-protein conjugate with a linear version and using molecular dynamics simulations, the research aims to highlight the potential of cyclic polymers in improving therapeutic applications.
View Article and Find Full Text PDF